United States Non-opioid Pain Patches Market Report 2017

November 2017 | 108 pages | ID: UC1941E2CBBEN
QYResearch

Abstracts

In this report, the United States Non-opioid Pain Patches market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Non-opioid Pain Patches in these regions, from 2012 to 2022 (forecast).

United States Non-opioid Pain Patches market competition by top manufacturers/players, with Non-opioid Pain Patches sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• GlaxoSmithKline
• Johnson & Johnson
• Novartis AG
• Mylan N.V.
• Teva Pharmaceutical Industries
• Hisamitsu Pharmaceutical
• TEH SENG Pharmaceutical
• Teikoku Seiyaku
• IBSA Institut Biochimque SA
• Acorda Therapeutics
• Allergan PLC
• Endo International

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Lidocaine Patch
• Diclofenac Patch
• Methyl Salicylate Patch
• Capsaicin Patch
• Ketoprofen Patch
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital Pharmacies
• Independent Pharmacies & Drug Stores
• Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Non-opioid Pain Patches Market Report 2017

1 NON-OPIOID PAIN PATCHES OVERVIEW

1.1 Product Overview and Scope of Non-opioid Pain Patches
1.2 Classification of Non-opioid Pain Patches by Product Category
  1.2.1 United States Non-opioid Pain Patches Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Non-opioid Pain Patches Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Lidocaine Patch
  1.2.4 Diclofenac Patch
  1.2.5 Methyl Salicylate Patch
  1.2.6 Capsaicin Patch
  1.2.7 Ketoprofen Patch
  1.2.8 Other
1.3 United States Non-opioid Pain Patches Market by Application/End Users
  1.3.1 United States Non-opioid Pain Patches Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital Pharmacies
  1.3.3 Independent Pharmacies & Drug Stores
  1.3.4 Online Pharmacies
1.4 United States Non-opioid Pain Patches Market by Region
  1.4.1 United States Non-opioid Pain Patches Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Non-opioid Pain Patches Status and Prospect (2012-2022)
  1.4.3 Southwest Non-opioid Pain Patches Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Non-opioid Pain Patches Status and Prospect (2012-2022)
  1.4.5 New England Non-opioid Pain Patches Status and Prospect (2012-2022)
  1.4.6 The South Non-opioid Pain Patches Status and Prospect (2012-2022)
  1.4.7 The Midwest Non-opioid Pain Patches Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Non-opioid Pain Patches (2012-2022)
  1.5.1 United States Non-opioid Pain Patches Sales and Growth Rate (2012-2022)
  1.5.2 United States Non-opioid Pain Patches Revenue and Growth Rate (2012-2022)

2 UNITED STATES NON-OPIOID PAIN PATCHES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Non-opioid Pain Patches Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Non-opioid Pain Patches Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Non-opioid Pain Patches Average Price by Players/Suppliers (2012-2017)
2.4 United States Non-opioid Pain Patches Market Competitive Situation and Trends
  2.4.1 United States Non-opioid Pain Patches Market Concentration Rate
  2.4.2 United States Non-opioid Pain Patches Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Non-opioid Pain Patches Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES NON-OPIOID PAIN PATCHES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Non-opioid Pain Patches Sales and Market Share by Region (2012-2017)
3.2 United States Non-opioid Pain Patches Revenue and Market Share by Region (2012-2017)
3.3 United States Non-opioid Pain Patches Price by Region (2012-2017)

4 UNITED STATES NON-OPIOID PAIN PATCHES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Non-opioid Pain Patches Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Non-opioid Pain Patches Revenue and Market Share by Type (2012-2017)
4.3 United States Non-opioid Pain Patches Price by Type (2012-2017)
4.4 United States Non-opioid Pain Patches Sales Growth Rate by Type (2012-2017)

5 UNITED STATES NON-OPIOID PAIN PATCHES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Non-opioid Pain Patches Sales and Market Share by Application (2012-2017)
5.2 United States Non-opioid Pain Patches Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES NON-OPIOID PAIN PATCHES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Non-opioid Pain Patches Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GlaxoSmithKline
  6.2.2 Non-opioid Pain Patches Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GlaxoSmithKline Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Johnson & Johnson
  6.3.2 Non-opioid Pain Patches Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Johnson & Johnson Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Novartis AG
  6.4.2 Non-opioid Pain Patches Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Novartis AG Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Mylan N.V.
  6.5.2 Non-opioid Pain Patches Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Mylan N.V. Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Teva Pharmaceutical Industries
  6.6.2 Non-opioid Pain Patches Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Teva Pharmaceutical Industries Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Hisamitsu Pharmaceutical
  6.7.2 Non-opioid Pain Patches Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 TEH SENG Pharmaceutical
  6.8.2 Non-opioid Pain Patches Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 TEH SENG Pharmaceutical Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Teikoku Seiyaku
  6.9.2 Non-opioid Pain Patches Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Teikoku Seiyaku Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 IBSA Institut Biochimque SA
  6.10.2 Non-opioid Pain Patches Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 IBSA Institut Biochimque SA Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Acorda Therapeutics
6.12 Allergan PLC
6.13 Endo International

7 NON-OPIOID PAIN PATCHES MANUFACTURING COST ANALYSIS

7.1 Non-opioid Pain Patches Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Non-opioid Pain Patches

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Non-opioid Pain Patches Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Non-opioid Pain Patches Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Non-opioid Pain Patches Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Non-opioid Pain Patches Sales Volume Forecast by Type (2017-2022)
11.3 United States Non-opioid Pain Patches Sales Volume Forecast by Application (2017-2022)
11.4 United States Non-opioid Pain Patches Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Non-opioid Pain Patches
Figure United States Non-opioid Pain Patches Market Size (K Pcs) by Type (2012-2022)
Figure United States Non-opioid Pain Patches Sales Volume Market Share by Type (Product Category) in 2016
Figure Lidocaine Patch Product Picture
Figure Diclofenac Patch Product Picture
Figure Methyl Salicylate Patch Product Picture
Figure Capsaicin Patch Product Picture
Figure Ketoprofen Patch Product Picture
Figure Other Product Picture
Figure United States Non-opioid Pain Patches Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Non-opioid Pain Patches by Application in 2016
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Independent Pharmacies & Drug Stores Examples
Table Key Downstream Customer in Independent Pharmacies & Drug Stores
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure United States Non-opioid Pain Patches Market Size (Million USD) by Region (2012-2022)
Figure The West Non-opioid Pain Patches Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Non-opioid Pain Patches Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Non-opioid Pain Patches Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Non-opioid Pain Patches Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Non-opioid Pain Patches Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Non-opioid Pain Patches Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Non-opioid Pain Patches Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Non-opioid Pain Patches Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Non-opioid Pain Patches Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Non-opioid Pain Patches Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Non-opioid Pain Patches Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Non-opioid Pain Patches Sales Share by Players/Suppliers
Figure 2017 United States Non-opioid Pain Patches Sales Share by Players/Suppliers
Figure United States Non-opioid Pain Patches Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Non-opioid Pain Patches Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Non-opioid Pain Patches Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Non-opioid Pain Patches Revenue Share by Players/Suppliers
Figure 2017 United States Non-opioid Pain Patches Revenue Share by Players/Suppliers
Table United States Market Non-opioid Pain Patches Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Non-opioid Pain Patches Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Non-opioid Pain Patches Market Share of Top 3 Players/Suppliers
Figure United States Non-opioid Pain Patches Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Non-opioid Pain Patches Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Non-opioid Pain Patches Product Category
Table United States Non-opioid Pain Patches Sales (K Pcs) by Region (2012-2017)
Table United States Non-opioid Pain Patches Sales Share by Region (2012-2017)
Figure United States Non-opioid Pain Patches Sales Share by Region (2012-2017)
Figure United States Non-opioid Pain Patches Sales Market Share by Region in 2016
Table United States Non-opioid Pain Patches Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Non-opioid Pain Patches Revenue Share by Region (2012-2017)
Figure United States Non-opioid Pain Patches Revenue Market Share by Region (2012-2017)
Figure United States Non-opioid Pain Patches Revenue Market Share by Region in 2016
Table United States Non-opioid Pain Patches Price (USD/Pcs) by Region (2012-2017)
Table United States Non-opioid Pain Patches Sales (K Pcs) by Type (2012-2017)
Table United States Non-opioid Pain Patches Sales Share by Type (2012-2017)
Figure United States Non-opioid Pain Patches Sales Share by Type (2012-2017)
Figure United States Non-opioid Pain Patches Sales Market Share by Type in 2016
Table United States Non-opioid Pain Patches Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Non-opioid Pain Patches Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Non-opioid Pain Patches by Type (2012-2017)
Figure Revenue Market Share of Non-opioid Pain Patches by Type in 2016
Table United States Non-opioid Pain Patches Price (USD/Pcs) by Types (2012-2017)
Figure United States Non-opioid Pain Patches Sales Growth Rate by Type (2012-2017)
Table United States Non-opioid Pain Patches Sales (K Pcs) by Application (2012-2017)
Table United States Non-opioid Pain Patches Sales Market Share by Application (2012-2017)
Figure United States Non-opioid Pain Patches Sales Market Share by Application (2012-2017)
Figure United States Non-opioid Pain Patches Sales Market Share by Application in 2016
Table United States Non-opioid Pain Patches Sales Growth Rate by Application (2012-2017)
Figure United States Non-opioid Pain Patches Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Non-opioid Pain Patches Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Non-opioid Pain Patches Sales Growth Rate (2012-2017)
Figure Pfizer Non-opioid Pain Patches Sales Market Share in United States (2012-2017)
Figure Pfizer Non-opioid Pain Patches Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Non-opioid Pain Patches Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Non-opioid Pain Patches Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Non-opioid Pain Patches Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Non-opioid Pain Patches Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Non-opioid Pain Patches Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Non-opioid Pain Patches Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Non-opioid Pain Patches Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Non-opioid Pain Patches Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Non-opioid Pain Patches Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis AG Non-opioid Pain Patches Sales Growth Rate (2012-2017)
Figure Novartis AG Non-opioid Pain Patches Sales Market Share in United States (2012-2017)
Figure Novartis AG Non-opioid Pain Patches Revenue Market Share in United States (2012-2017)
Table Mylan N.V. Basic Information List
Table Mylan N.V. Non-opioid Pain Patches Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Mylan N.V. Non-opioid Pain Patches Sales Growth Rate (2012-2017)
Figure Mylan N.V. Non-opioid Pain Patches Sales Market Share in United States (2012-2017)
Figure Mylan N.V. Non-opioid Pain Patches Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceutical Industries Basic Information List
Table Teva Pharmaceutical Industries Non-opioid Pain Patches Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Non-opioid Pain Patches Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Non-opioid Pain Patches Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceutical Industries Non-opioid Pain Patches Revenue Market Share in United States (2012-2017)
Table Hisamitsu Pharmaceutical Basic Information List
Table Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales Growth Rate (2012-2017)
Figure Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales Market Share in United States (2012-2017)
Figure Hisamitsu Pharmaceutical Non-opioid Pain Patches Revenue Market Share in United States (2012-2017)
Table TEH SENG Pharmaceutical Basic Information List
Table TEH SENG Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure TEH SENG Pharmaceutical Non-opioid Pain Patches Sales Growth Rate (2012-2017)
Figure TEH SENG Pharmaceutical Non-opioid Pain Patches Sales Market Share in United States (2012-2017)
Figure TEH SENG Pharmaceutical Non-opioid Pain Patches Revenue Market Share in United States (2012-2017)
Table Teikoku Seiyaku Basic Information List
Table Teikoku Seiyaku Non-opioid Pain Patches Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Teikoku Seiyaku Non-opioid Pain Patches Sales Growth Rate (2012-2017)
Figure Teikoku Seiyaku Non-opioid Pain Patches Sales Market Share in United States (2012-2017)
Figure Teikoku Seiyaku Non-opioid Pain Patches Revenue Market Share in United States (2012-2017)
Table IBSA Institut Biochimque SA Basic Information List
Table IBSA Institut Biochimque SA Non-opioid Pain Patches Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure IBSA Institut Biochimque SA Non-opioid Pain Patches Sales Growth Rate (2012-2017)
Figure IBSA Institut Biochimque SA Non-opioid Pain Patches Sales Market Share in United States (2012-2017)
Figure IBSA Institut Biochimque SA Non-opioid Pain Patches Revenue Market Share in United States (2012-2017)
Table Acorda Therapeutics Basic Information List
Table Allergan PLC Basic Information List
Table Endo International Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-opioid Pain Patches
Figure Manufacturing Process Analysis of Non-opioid Pain Patches
Figure Non-opioid Pain Patches Industrial Chain Analysis
Table Raw Materials Sources of Non-opioid Pain Patches Major Players/Suppliers in 2016
Table Major Buyers of Non-opioid Pain Patches
Table Distributors/Traders List
Figure United States Non-opioid Pain Patches Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Non-opioid Pain Patches Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Non-opioid Pain Patches Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Non-opioid Pain Patches Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Non-opioid Pain Patches Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Non-opioid Pain Patches Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Non-opioid Pain Patches Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Non-opioid Pain Patches Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Non-opioid Pain Patches Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Non-opioid Pain Patches Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Non-opioid Pain Patches Sales Volume Share Forecast by Region (2017-2022)
Figure United States Non-opioid Pain Patches Sales Volume Share Forecast by Region (2017-2022)
Figure United States Non-opioid Pain Patches Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources